J Gynecol Oncol.
2019 Sep;30(5):e98. 10.3802/jgo.2019.30.e98.
Aromatase inhibition in ovarian cancer: repeated signals of efficacy but tools for patient selection remain elusive
- Affiliations
-
- 1Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC IGMM, University of Edinburgh, Edinburgh, UK. charlie.gourley@ed.ac.uk
- KMID: 2457161
- DOI: http://doi.org/10.3802/jgo.2019.30.e98
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recovery of Ovarian Function with Aromatase Inhibitors: In Young Breast Cancer Patients (<45) with Chemotherapy-induced Amenorrhea
- GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways
- A Case of Pseudo-Meigs' Syndrome Associated with Ovarian Metastases from Breast Cancer
- Role of Ovarian Function Suppression in Premenopausal Women with Early Breast Cancer
- Maximal cytoreductive effort in epithelial ovarian cancer surgery
